FindTrial
Sign In

A comparative study of chirbilva fruit and bark in the management of eczema

A comprehensive study of Chirbilva[holoptelia integrifolia (Roxb.) Planch] and Comparative Clinical Evaluation of its Bark and Fruit in the Management of Eczema

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/031888
Enrollment
30
Registered
2021-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified Health Condition 2: L309- Dermatitis, unspecified

Interventions

Intervention1: chirbilva fruit: Powder of Chirabilva [Holoptelia integrifolia (Roxb.) Planch] fruit will be mixed with Tila Taila in sufficient ratio and applied on affected part of Skin Control Inte

Sponsors

Gaurang Prajapati
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a. Patients between age group of 18-60 years. b. Patients having sign and symptoms of eczema fulfilling the diagnosis.

Exclusion criteria

Exclusion criteria: a. Patients having age less than 18 years and more than 60 years. b. Patients with any other associated clinical condition. c. Pregnant and lactating women. d. Patients who are on steroid therapy.

Design outcomes

Primary

MeasureTime frame
changes in sign and symptoms of eczemaTimepoint: 21 days—

Secondary

MeasureTime frame
changes in sign and symptoms of eczemaTimepoint: 21 days—

Countries

India

Contacts

Public ContactDr Gaurang prajapati

J.S.Ayurveda mahavidhyalaya

drkalapi@rediffmail.com9687380328

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026